Trial Site Detail
Drug: |
Sorafenib (Nexavar, BAY 43-9006) |
|||
|---|---|---|---|---|
Trial: |
Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Ongoing, but not recruiting |
|||
UC-Davis4501 X St Suite 3017 |
Principal Investigator: |
David Gandara, MD |
|---|---|
Contact: |
916-734-3771 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
UC-Davis Website: |
https://clinicaltrials.ucdavis.edu/ |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.